(CIDRAP News) The Infectious Diseases Society of America (IDSA) is urging Bayer Corp. to comply with a proposed federal regulatory action and withdraw enrofloxacin (Baytril) from the market because of the concern that its use in poultry promotes drug-resistant bacteria.
(CIDRAP News) Public health and infectious disease experts today called on the United States to develop a "master plan" for development of pandemic influenza vaccines in order to translate scientific advances more rapidly into improved pandemic preparedness.
(CIDRAP News) The nation's largest public health group, the American Public Health Association (APHA), yesterday released recommendations aimed at strengthening existing federal strategies for pandemic preparedness and encouraging local officials and businesses to play key roles.
(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
(CIDRAP News) Requests to use the intravenous (IV) antiviral drug peramivir in hospitalized H1N1 flu patients came quickly after the government issued an emergency use authorization (EUA) Oct 23, a Centers for Disease Control and Prevention (CDC) official said today.
(CIDRAP News) Federal officials today allowed the public health emergency declaration that was prompted by the H1N1 influenza outbreak last year to lapse, signaling an end to emergency authorizations for certain special uses of antiviral drugs and other items.